3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
4
Observational
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
18
Melanoma
13
Neoplasms
5
Head and Neck Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Lung Neoplasms
4
Stomach Neoplasms
3
Neoplasm Metastasis
2
Kidney Neoplasms
2
Gastrointestinal Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma, Hepatocellular
2
Thyroid Neoplasms
1
Skin Neoplasms
1
Sexual Dysfunction, Physiological
1
Sarcopenia
1
Recurrent Squamous Cell Lung Carcinoma
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Oropharyngeal Neoplasms
1
Neoplasms, Squamous Cell
1
Motor Activity
1
Lung Squamous Cell Carcinoma Stage IV
1
Locally Advanced Melanoma
1
Locally Advanced Gastric Cancer
1
Liver Diseases
1
Hereditary Sensory and Autonomic Neuropathies
1
Eunuchism
1
Esophageal Neoplasms
1
Erectile Dysfunction
1
Interventions
Immune Checkpoint Inhibitors
2
pembrolizumab
1
durvalumab
1
atezolizumab
1
Nivolumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
Nivolumab
×
Clear all
NCT07192926
2026-02-20
SARCO-CTI
Ankara Etlik City Hospital
Completed
131 enrolled